CD79A and myeloid sarcoma: Analysis of the data, stratified according to gender within each group, showed that in both MS patients and HCs, the magnitude of ETX-specific IgM and IgA responses was similar in women compared to men, while IgG response was significantly increased in men (Figure 2B).